Cargando…
Founder mutation in the PMM2 promotor causes hyperinsulinemic hypoglycaemia/polycystic kidney disease (HIPKD)
BACKGROUND: Polycystic kidney disease with hyperinsulinaemic hypoglycaemia (HIPKD) is a recently described disease caused by a single nucleotide variant, c.‐167G>T, in the promoter region of PMM2 (encoding phosphomannomutase 2), either in homozygosity or compound heterozygosity with a pathogenic...
Autores principales: | Islam, Sumaya, Tekman, Mehmet, Flanagan, Sarah E., Guay‐Woodford, Lisa, Hussain, Khalid, Ellard, Sian, Kleta, Robert, Bockenhauer, Detlef, Stanescu, Horia, Iancu, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683636/ https://www.ncbi.nlm.nih.gov/pubmed/33811480 http://dx.doi.org/10.1002/mgg3.1674 |
Ejemplares similares
-
Founder mutation in KCNJ10 in Pakistani patients with EAST syndrome
por: Abdelhadi, Ola, et al.
Publicado: (2016) -
OVAS: an open-source variant analysis suite with inheritance modelling
por: Mozere, Monika, et al.
Publicado: (2018) -
EAST syndrome: Clinical, pathophysiological, and genetic aspects of mutations in KCNJ10
por: Abdelhadi, Ola, et al.
Publicado: (2016) -
Sirolimus therapy following subtotal pancreatectomy in neonatal hyperinsulinemic hypoglycaemia: a case report
por: Abraham, Mary, et al.
Publicado: (2015) -
Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X)
por: Cappella, Michela, et al.
Publicado: (2015)